Finance

Beta
Lists
1SXP:VIE
SCHOTT Pharma AG & Co KgaA
€17.66
+2.44%
(+0.42) 1D
Jun 4, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1SXP...
Open
€17.38
High
€17.66
Low
€17.38
Mkt. cap
2.61B
Avg. vol.
30.00
Volume
0.00
Dividend
1.02%
Quarterly dividend
€0.04
Ex-dividend date
Feb 4, 2026
P/E ratio
18.54
52-wk high
€30.10
52-wk low
€12.74
EPS
€0.95
No. of employees
5K
Open
€17.38
High
€17.66
Low
€17.38
Mkt. cap
2.61B
Avg. vol.
30.00
Volume
0.00
Dividend
1.02%
Quarterly dividend
€0.04
Ex-dividend date
Feb 4, 2026
P/E ratio
18.54
52-wk high
€30.10
52-wk low
€12.74
EPS
€0.95
No. of employees
5K
News stories
From sources across the web
Profile
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
About SCHOTT Pharma AG & Co KgaA
CEO-
Employees4.84K
FoundedAug 1, 2022
Headquarters-
SectorHealth care
Websiteschott-pharma.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
256.46M
247.58M
240.19M
247.88M
Cost of goods sold
160.36M
171.50M
160.44M
172.78M
Cost of revenue
160.36M
171.50M
160.44M
172.78M
Research and development expenses
7.32M
6.36M
7.34M
6.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32.24M
32.89M
33.73M
32.51M
Operating expense
35.98M
35.95M
40.70M
35.55M
Total operating expenses
196.34M
207.45M
201.14M
208.33M
Operating income
60.12M
40.14M
39.05M
39.55M
Other non operating income
10.00K
-61.00K
-79.00K
-212.00K
EBT including unusual items
60.14M
41.76M
42.04M
40.31M
EBT excluding unusual items
60.14M
41.02M
42.04M
40.31M
Income tax expense
14.41M
8.09M
8.76M
9.17M
Effective tax rate
23.96%
19.37%
20.84%
22.76%
Other operating expenses
-3.59M
-3.30M
-366.00K
-3.01M
Net income
45.56M
33.56M
33.18M
31.01M
Net profit margin
17.77%
13.55%
13.81%
12.51%
Earnings per share
0.30
0.22
0.22
0.21
Interest and investment income
1.80M
2.02M
2.33M
1.84M
Interest expense
-4.91M
-4.71M
-4.00M
-4.01M
Net interest expenses
-3.11M
-2.69M
-1.67M
-2.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
79.85M
56.70M
60.46M
61.41M
Gain or loss from assets sale
-92.00K
-88.00K
-48.00K
-72.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer